A pharmaceutical pricing agreement between the United Kingdom and United States will require the National Health Service to spend 25% more on innovative medicines by 2035. This commitment, projected by …
© Copyright by THE FRANCE TIMES (A Digital Media Brand owned by AMAZON MEDIA LLC).